RESOURCES

Blogs

Insight at the intersection of data science and real-world health

The Talking Room

Demystifying AI, LLMs and machine learning

Use Cases

How teams put the signals to work

Compliance Hub

Data integrity, ethical AI and regulatory standards

DrugVoice

Built to be defensible.

Compliance, ethics, and data integrity are part of the process.

TMLABS

About us

Where our proprietary models are trained, tested and refined

Articles & scientific publications

Peer-reviewed methodologies and validated outcomes

Latest paper

The New GLP-1 Consumer

Articles & Scientific Publications

DRUGVOICE

DrugVoice

Measure how your messaging lands and evidence what moved

SEE IT IN ACTION

Bring us a question you can’t answer.

We’ll show you what the conversation already contains, using your therapy area and your audience.

ABOUT US

About us

Where our proprietary models are trained, tested and refined

ESG

Responsible innovation and ethical data practice

WHO WE ARE

Data scientists who speak pharma.

A team built around one problem: making real-world conversation usable at scale.

Synthetic Personas vs Evidence-Based Personas: Moving from “What They Say” to “What They Do”

The Evolution of Personas 

For years, personas have supported businesses to humanize their audiences. Traditionally, these personas were research-driven but static, frozen in time. With the rise of generative AI, synthetic personas (avatar-led) have become fast, scalable, and engaging. But realism doesn’t guarantee accuracy.  A more advanced approach is now taking hold: evidence-based personas built on real-life data and signals, optimized with synthetic data. These personas are not just storytelling tools, they are predictive systems that help forecast behavior and inform decisions. 

Synthetic Personas vs Evidence-Based Personas: Key Differences 

 

Depth, Variability, and Realism 

  • Behavioral Depth: Synthetic personas capture surface-level opinions and preferences, while evidence-based personas delve into decision drivers, constraints, and behavioral variability 
  • Ability to Model Variability: Synthetic personas are limited and heavily dependent on prompts. Evidence-based personas capture heterogeneity, edge cases, and uncertainty at scale 
  • Link to Real-World Behavior: Synthetic personas are indirect and largely unvalidated. Evidence-based personas are directly tied to real-life signals and behavioral patterns. 

Use Cases and Outputs 

  • Synthetic Personas: Ideal for message testing, content validation, and training simulations. They generate simulated responses and opinions 
  • Evidence-Based Personas: Suited for behavioral modelling, decision optimization, and scenario simulation. They deliver actionable, predictive behavioral insights 

Risk and Strategic Value 

  • Risk Profile: Synthetic personas risk producing “plausible but untrue” outputs. Evidence-based personas may introduce model bias, but this can be managed through rigorous validation and data governance 
  • Analogy: Synthetic personas resemble AI-generated focus groups, while evidence-based personas function as behavioral digital twins with a commercial lens 
  • Strategic Value: Synthetic personas improve messaging efficiency; evidence-based personas improve decision-making and real-life outcomes 

Why This Shift Matters 

As organizations become more data-driven, bridging the gap between insight and action becomes critical. Synthetic personas help teams feel closer to customers, enabling rapid exploration and iteration. Evidence-based personas help organizations act with confidence, supporting strategy, forecasting and optimization.  The future is not about choosing one over the other – but knowing when to use each: 

  • Synthetic personas for exploration, creativity, and quick validation 
  • Evidence-based personas for strategic decisions, predictive modelling, and optimizing outcomes. 

Conclusion 

We are moving from a world of imagined audiences to modelled behaviors.  The question is no longer: “Does this sound right?”  It becomes: “Will this work in the real world?”  Organizations that adopt evidence-based personas grounded in real data and strengthened by synthetic inputs may be better positioned to improve decision-making and forecasting than those relying solely on simulated narratives. Ultimately, better decisions come from understanding not just what people say, but what they are most likely to do. 

References 

Sign Up to Stay Ahead of Message Impact

Discover how Pharma marketeers are finally measuring which messages change HCP behavior. Our newsletter shares evidence-led insights powered by DrugVoice and the Message Resonance Score™ so you can predict and prove message impact—before prescriptions are written.

Subscribe on LinkedIn

Read More

#
$